Gleason 6 Prostate Tumors Diagnosed in the PSA Era Do Not Demonstrate the Capacity for Metastatic Spread at the Time of Radical Prostatectomy-Reference-Cited by-同舟云学术

Gleason 6 Prostate Tumors Diagnosed in the PSA Era Do Not Demonstrate the Capacity for Metastatic Spread at the Time of Radical Prostatectomy

Published:2013-07 Issue:1 Volume:82 Page:148-153
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Donin Nicholas M.,Laze Juliana,Zhou Ming,Ren Qinghu,Lepor Herbert

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005;Welch;J Natl Cancer Inst,2009

3. American Cancer Society Facts and Figures 2012. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed April 16, 2013.

4. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen;Punglia;N Engl J Med,2003

5. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy;Singh;J Urol,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UQCRB and LBH are correlated with Gleason score progression in prostate cancer: Spatial transcriptomics and experimental validation;Computational and Structural Biotechnology Journal;2024-12

2. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients;Pathology;2023-11

3. Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists’ Perspective;Journal of Urology;2023-07

4. Renaming Grade Group 1 Prostate “Cancer” From a Pathology Perspective: A Call for Multidisciplinary Discussion;Advances in Anatomic Pathology;2023-04-17

5. Renaming Gleason Score 6 Prostate to Noncancer: A Flawed Idea Scientifically and for Patient Care;Journal of Clinical Oncology;2022-09-20